These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 16496609

  • 21. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R, Liu Z, Chen Z, Li L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
    [Abstract] [Full Text] [Related]

  • 22. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR.
    Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
    [Abstract] [Full Text] [Related]

  • 23. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 24. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.
    Thromb Res; 2008 Mar; 122(6):854-60. PubMed ID: 18423526
    [Abstract] [Full Text] [Related]

  • 25. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
    Sartori MT, Vettor R, De Pergola G, De Mitrio V, Saggiorato G, Della Mea P, Patrassi GM, Lombardi AM, Fabris R, Girolami A.
    Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
    [Abstract] [Full Text] [Related]

  • 26. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer.
    Błasiak J, Smolarz B.
    Acta Biochim Pol; 2000 Nov; 47(1):191-9. PubMed ID: 10961693
    [Abstract] [Full Text] [Related]

  • 27. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
    Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, Nishimura M.
    Clin Exp Allergy; 2006 Jul; 36(7):872-6. PubMed ID: 16839401
    [Abstract] [Full Text] [Related]

  • 28. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
    Kario K, Matsuo T, Kobayashi H, Kanai N, Hoshide S, Mitsuhashi T, Ikeda U, Nishiuma S, Matsuo M, Shimada K.
    J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
    [Abstract] [Full Text] [Related]

  • 29. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M.
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [Abstract] [Full Text] [Related]

  • 30. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
    Estellés A, Dalmau J, Falcó C, Berbel O, Castelló R, España F, Aznar J.
    Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
    [Abstract] [Full Text] [Related]

  • 31. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H, Wallmark K, Jern S, Karlsson L.
    Thromb Res; 2008 Aug; 121(6):793-7. PubMed ID: 17884148
    [Abstract] [Full Text] [Related]

  • 32. The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease.
    Gardemann A, Lohre J, Katz N, Tillmanns H, Hehrlein FW, Haberbosch W.
    Thromb Haemost; 1999 Sep; 82(3):1121-6. PubMed ID: 10494775
    [Abstract] [Full Text] [Related]

  • 33. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 34. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
    Sakhteh M, Poopak B, Amirizadeh N, Shamshiri A, Bagheri A, Faranoush M.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
    [Abstract] [Full Text] [Related]

  • 35. GNB3 gene C825T and ACE gene I/D polymorphisms in essential hypertension in a Kazakh genetic isolate.
    Wang X, Wang S, Lin R, Jiang X, Cheng Z, Turdi J, Ding J, Wu G, Lu X, Wen H.
    J Hum Hypertens; 2004 Sep; 18(9):663-8. PubMed ID: 15042113
    [Abstract] [Full Text] [Related]

  • 36. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Sep; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 37. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z, Jhun B, Jung SY, Oh CK.
    J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
    [Abstract] [Full Text] [Related]

  • 38. Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.
    Eroglu A, Ulu A, Cam R, Akar N.
    J BUON; 2006 Apr; 11(4):481-4. PubMed ID: 17309181
    [Abstract] [Full Text] [Related]

  • 39. Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in a Polish population.
    Dzida G, Sobstyl J, Puzniak A, Golon P, Mosiewicz J, Hanzlik J.
    Med Sci Monit; 2001 Apr; 7(6):1236-41. PubMed ID: 11687736
    [Abstract] [Full Text] [Related]

  • 40. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury].
    Lu LH, Chen H, Yu L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.